Elliott to support Actelion nominees

Friday 15 April 2011 00:00 BST

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Elliott Advisors, the dissident Actelion shareholder which has proposed six independent directors for the Swiss biotech's board, partially welcomed the company's recent nomination of former GlaxoSmithKline boss Jean-Pierre Garnier and ex-Schering-Plough finance chief Robert Bertolini as board members.

Elliott said that while it would support the move, which it characterised as a step in the right direction, it did not go far enough to create real change.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

Elliott to support Actelion nominees

Join our commenting forum

Thank you for registering